Table of Content

1 Market Overview of Anti-Infective Therapy
1.1 Anti-Infective Therapy Market Overview
1.1.1 Anti-Infective Therapy Product Scope
1.1.2 Anti-Infective Therapy Market Status and Outlook
1.2 Global Anti-Infective Therapy Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Anti-Infective Therapy Market Size by Region (2018-2034)
1.4 Global Anti-Infective Therapy Historic Market Size by Region (2018-2024)
1.5 Global Anti-Infective Therapy Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Anti-Infective Therapy Market Size (2018-2034)
1.6.1 North America Anti-Infective Therapy Market Size (2018-2034)
1.6.2 Europe Anti-Infective Therapy Market Size (2018-2034)
1.6.3 Asia-Pacific Anti-Infective Therapy Market Size (2018-2034)
1.6.4 Latin America Anti-Infective Therapy Market Size (2018-2034)
1.6.5 Middle East & Africa Anti-Infective Therapy Market Size (2018-2034)
2 Anti-Infective Therapy Market by Type
2.1 Introduction
2.1.1 Penicillin
2.1.2 Sulphonamides
2.1.3 Aminoglycosides
2.1.4 Fluoroquinolones
2.1.5 Antifungals
2.1.6 Antiprotozoal
2.1.7 Others
2.2 Global Anti-Infective Therapy Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Anti-Infective Therapy Historic Market Size by Type (2018-2024)
2.2.2 Global Anti-Infective Therapy Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Anti-Infective Therapy Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Anti-Infective Therapy Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Anti-Infective Therapy Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Anti-Infective Therapy Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Anti-Infective Therapy Revenue Breakdown by Type (2018-2034)
3 Anti-Infective Therapy Market Overview by Application
3.1 Introduction
3.1.1 Home User
3.1.2 Hospitals/Clinics
3.1.3 Ambulatory Surgery Centres
3.1.4 Others
3.2 Global Anti-Infective Therapy Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Anti-Infective Therapy Historic Market Size by Application (2018-2024)
3.2.2 Global Anti-Infective Therapy Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Anti-Infective Therapy Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Anti-Infective Therapy Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Anti-Infective Therapy Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Anti-Infective Therapy Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Anti-Infective Therapy Revenue Breakdown by Application (2018-2034)
4 Anti-Infective Therapy Competition Analysis by Players
4.1 Global Anti-Infective Therapy Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Infective Therapy as of 2022)
4.3 Date of Key Players Enter into Anti-Infective Therapy Market
4.4 Global Top Players Anti-Infective Therapy Headquarters and Area Served
4.5 Key Players Anti-Infective Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Anti-Infective Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories Ltd.
5.1.1 Abbott Laboratories Ltd. Profile
5.1.2 Abbott Laboratories Ltd. Main Business
5.1.3 Abbott Laboratories Ltd. Anti-Infective Therapy Products, Services and Solutions
5.1.4 Abbott Laboratories Ltd. Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.1.5 Abbott Laboratories Ltd. Recent Developments
5.2 Cipla Ltd.
5.2.1 Cipla Ltd. Profile
5.2.2 Cipla Ltd. Main Business
5.2.3 Cipla Ltd. Anti-Infective Therapy Products, Services and Solutions
5.2.4 Cipla Ltd. Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.2.5 Cipla Ltd. Recent Developments
5.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris))
5.3.1 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Profile
5.3.2 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Main Business
5.3.3 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Products, Services and Solutions
5.3.4 Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.3.5 Glenmark Pharmaceuticals Limited Recent Developments
5.4 Glenmark Pharmaceuticals Limited
5.4.1 Glenmark Pharmaceuticals Limited Profile
5.4.2 Glenmark Pharmaceuticals Limited Main Business
5.4.3 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Products, Services and Solutions
5.4.4 Glenmark Pharmaceuticals Limited Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.4.5 Glenmark Pharmaceuticals Limited Recent Developments
5.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd)
5.5.1 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Profile
5.5.2 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Main Business
5.5.3 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Products, Services and Solutions
5.5.4 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.5.5 GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Developments
5.6 Lupin Limited
5.6.1 Lupin Limited Profile
5.6.2 Lupin Limited Main Business
5.6.3 Lupin Limited Anti-Infective Therapy Products, Services and Solutions
5.6.4 Lupin Limited Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.6.5 Lupin Limited Recent Developments
5.7 Panacea Biotec Limited
5.7.1 Panacea Biotec Limited Profile
5.7.2 Panacea Biotec Limited Main Business
5.7.3 Panacea Biotec Limited Anti-Infective Therapy Products, Services and Solutions
5.7.4 Panacea Biotec Limited Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.7.5 Panacea Biotec Limited Recent Developments
5.8 Novartis AG
5.8.1 Novartis AG Profile
5.8.2 Novartis AG Main Business
5.8.3 Novartis AG Anti-Infective Therapy Products, Services and Solutions
5.8.4 Novartis AG Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.8.5 Novartis AG Recent Developments
5.9 Pfizer, Inc.
5.9.1 Pfizer, Inc. Profile
5.9.2 Pfizer, Inc. Main Business
5.9.3 Pfizer, Inc. Anti-Infective Therapy Products, Services and Solutions
5.9.4 Pfizer, Inc. Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.9.5 Pfizer, Inc. Recent Developments
5.10 Ranbaxy Laboratories Limited
5.10.1 Ranbaxy Laboratories Limited Profile
5.10.2 Ranbaxy Laboratories Limited Main Business
5.10.3 Ranbaxy Laboratories Limited Anti-Infective Therapy Products, Services and Solutions
5.10.4 Ranbaxy Laboratories Limited Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.10.5 Ranbaxy Laboratories Limited Recent Developments
5.11 Sun Pharmaceutical Industries Limited
5.11.1 Sun Pharmaceutical Industries Limited Profile
5.11.2 Sun Pharmaceutical Industries Limited Main Business
5.11.3 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Products, Services and Solutions
5.11.4 Sun Pharmaceutical Industries Limited Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.11.5 Sun Pharmaceutical Industries Limited Recent Developments
5.12 AstraZeneca plc
5.12.1 AstraZeneca plc Profile
5.12.2 AstraZeneca plc Main Business
5.12.3 AstraZeneca plc Anti-Infective Therapy Products, Services and Solutions
5.12.4 AstraZeneca plc Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.12.5 AstraZeneca plc Recent Developments
5.13 Johnson & Johnson
5.13.1 Johnson & Johnson Profile
5.13.2 Johnson & Johnson Main Business
5.13.3 Johnson & Johnson Anti-Infective Therapy Products, Services and Solutions
5.13.4 Johnson & Johnson Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.13.5 Johnson & Johnson Recent Developments
5.14 WOCKHARDT
5.14.1 WOCKHARDT Profile
5.14.2 WOCKHARDT Main Business
5.14.3 WOCKHARDT Anti-Infective Therapy Products, Services and Solutions
5.14.4 WOCKHARDT Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.14.5 WOCKHARDT Recent Developments
5.15 F. Hoffmann-La Roche Ltd
5.15.1 F. Hoffmann-La Roche Ltd Profile
5.15.2 F. Hoffmann-La Roche Ltd Main Business
5.15.3 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Products, Services and Solutions
5.15.4 F. Hoffmann-La Roche Ltd Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.15.5 F. Hoffmann-La Roche Ltd Recent Developments
5.16 Sanofi
5.16.1 Sanofi Profile
5.16.2 Sanofi Main Business
5.16.3 Sanofi Anti-Infective Therapy Products, Services and Solutions
5.16.4 Sanofi Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.16.5 Sanofi Recent Developments
5.17 Merck
5.17.1 Merck Profile
5.17.2 Merck Main Business
5.17.3 Merck Anti-Infective Therapy Products, Services and Solutions
5.17.4 Merck Anti-Infective Therapy Revenue (US$ Million) & (2018-2024)
5.17.5 Merck Recent Developments
6 North America
6.1 North America Anti-Infective Therapy Market Size by Country (2018-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Anti-Infective Therapy Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anti-Infective Therapy Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anti-Infective Therapy Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anti-Infective Therapy Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anti-Infective Therapy Market Dynamics
11.1 Anti-Infective Therapy Industry Trends
11.2 Anti-Infective Therapy Market Drivers
11.3 Anti-Infective Therapy Market Challenges
11.4 Anti-Infective Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Anti-Infective Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Anti-Infective Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Anti-Infective Therapy Market Size Share by Region (2018-2024)
Table 4. Global Anti-Infective Therapy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Anti-Infective Therapy Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Anti-Infective Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Anti-Infective Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Anti-Infective Therapy Revenue Market Share by Type (2018-2024)
Table 9. Global Anti-Infective Therapy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Anti-Infective Therapy Revenue Market Share by Type (2024-2034)
Table 11. North America Anti-Infective Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Anti-Infective Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Anti-Infective Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Anti-Infective Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Anti-Infective Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Anti-Infective Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Anti-Infective Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Anti-Infective Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Anti-Infective Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Anti-Infective Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Anti-Infective Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Anti-Infective Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Anti-Infective Therapy Revenue Market Share by Application (2018-2024)
Table 24. Global Anti-Infective Therapy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Anti-Infective Therapy Revenue Market Share by Application (2024-2034)
Table 26. North America Anti-Infective Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Anti-Infective Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Anti-Infective Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Anti-Infective Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Anti-Infective Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Anti-Infective Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Anti-Infective Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Anti-Infective Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Anti-Infective Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Anti-Infective Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Anti-Infective Therapy Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Anti-Infective Therapy Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Infective Therapy as of 2022)
Table 39. Date of Key Players Enter into Anti-Infective Therapy Market
Table 40. Global Anti-Infective Therapy Key Players Headquarters and Area Served
Table 41. Anti-Infective Therapy Product Solution and Service
Table 42. Global Anti-Infective Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Abbott Laboratories Ltd. Basic Information List
Table 45. Abbott Laboratories Ltd. Description and Business Overview
Table 46. Abbott Laboratories Ltd. Anti-Infective Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Anti-Infective Therapy Business of Abbott Laboratories Ltd. (2018-2024)
Table 48. Abbott Laboratories Ltd. Recent Developments
Table 49. Cipla Ltd. Basic Information List
Table 50. Cipla Ltd. Description and Business Overview
Table 51. Cipla Ltd. Anti-Infective Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Anti-Infective Therapy Business of Cipla Ltd. (2018-2024)
Table 53. Cipla Ltd. Recent Developments
Table 54. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Basic Information List
Table 55. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Description and Business Overview
Table 56. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Anti-Infective Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Anti-Infective Therapy Business of Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) (2018-2024)
Table 58. Athanas Enterprise Private Limited(Claris Lifesciences Limited (Claris)) Recent Developments
Table 59. Glenmark Pharmaceuticals Limited Basic Information List
Table 60. Glenmark Pharmaceuticals Limited Description and Business Overview
Table 61. Glenmark Pharmaceuticals Limited Anti-Infective Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Anti-Infective Therapy Business of Glenmark Pharmaceuticals Limited (2018-2024)
Table 63. Glenmark Pharmaceuticals Limited Recent Developments
Table 64. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Basic Information List
Table 65. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Description and Business Overview
Table 66. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Anti-Infective Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Anti-Infective Therapy Business of GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) (2018-2024)
Table 68. GlaxoSmithKline plc.(GlaxoSmithKline Pharmaceuticals Ltd) Recent Developments
Table 69. Lupin Limited Basic Information List
Table 70. Lupin Limited Description and Business Overview
Table 71. Lupin Limited Anti-Infective Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Anti-Infective Therapy Business of Lupin Limited (2018-2024)
Table 73. Lupin Limited Recent Developments
Table 74. Panacea Biotec Limited Basic Information List
Table 75. Panacea Biotec Limited Description and Business Overview
Table 76. Panacea Biotec Limited Anti-Infective Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Anti-Infective Therapy Business of Panacea Biotec Limited (2018-2024)
Table 78. Panacea Biotec Limited Recent Developments
Table 79. Novartis AG Basic Information List
Table 80. Novartis AG Description and Business Overview
Table 81. Novartis AG Anti-Infective Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Anti-Infective Therapy Business of Novartis AG (2018-2024)
Table 83. Novartis AG Recent Developments
Table 84. Pfizer, Inc. Basic Information List
Table 85. Pfizer, Inc. Description and Business Overview
Table 86. Pfizer, Inc. Anti-Infective Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Anti-Infective Therapy Business of Pfizer, Inc. (2018-2024)
Table 88. Pfizer, Inc. Recent Developments
Table 89. Ranbaxy Laboratories Limited Basic Information List
Table 90. Ranbaxy Laboratories Limited Description and Business Overview
Table 91. Ranbaxy Laboratories Limited Anti-Infective Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Anti-Infective Therapy Business of Ranbaxy Laboratories Limited (2018-2024)
Table 93. Ranbaxy Laboratories Limited Recent Developments
Table 94. Sun Pharmaceutical Industries Limited Basic Information List
Table 95. Sun Pharmaceutical Industries Limited Description and Business Overview
Table 96. Sun Pharmaceutical Industries Limited Anti-Infective Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Anti-Infective Therapy Business of Sun Pharmaceutical Industries Limited (2018-2024)
Table 98. Sun Pharmaceutical Industries Limited Recent Developments
Table 99. AstraZeneca plc Basic Information List
Table 100. AstraZeneca plc Description and Business Overview
Table 101. AstraZeneca plc Anti-Infective Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Anti-Infective Therapy Business of AstraZeneca plc (2018-2024)
Table 103. AstraZeneca plc Recent Developments
Table 104. Johnson & Johnson Basic Information List
Table 105. Johnson & Johnson Description and Business Overview
Table 106. Johnson & Johnson Anti-Infective Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Anti-Infective Therapy Business of Johnson & Johnson (2018-2024)
Table 108. Johnson & Johnson Recent Developments
Table 109. WOCKHARDT Basic Information List
Table 110. WOCKHARDT Description and Business Overview
Table 111. WOCKHARDT Anti-Infective Therapy Products, Services and Solutions
Table 112. Revenue (US$ Million) in Anti-Infective Therapy Business of WOCKHARDT (2018-2024)
Table 113. WOCKHARDT Recent Developments
Table 114. F. Hoffmann-La Roche Ltd Basic Information List
Table 115. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 116. F. Hoffmann-La Roche Ltd Anti-Infective Therapy Products, Services and Solutions
Table 117. Revenue (US$ Million) in Anti-Infective Therapy Business of F. Hoffmann-La Roche Ltd (2018-2024)
Table 118. F. Hoffmann-La Roche Ltd Recent Developments
Table 119. Sanofi Basic Information List
Table 120. Sanofi Description and Business Overview
Table 121. Sanofi Anti-Infective Therapy Products, Services and Solutions
Table 122. Revenue (US$ Million) in Anti-Infective Therapy Business of Sanofi (2018-2024)
Table 123. Sanofi Recent Developments
Table 124. Merck Basic Information List
Table 125. Merck Description and Business Overview
Table 126. Merck Anti-Infective Therapy Products, Services and Solutions
Table 127. Revenue (US$ Million) in Anti-Infective Therapy Business of Merck (2018-2024)
Table 128. Merck Recent Developments
Table 129. North America Anti-Infective Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 130. North America Anti-Infective Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 131. Europe Anti-Infective Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 132. Europe Anti-Infective Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 133. Asia-Pacific Anti-Infective Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 134. Asia-Pacific Anti-Infective Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 135. Asia-Pacific Anti-Infective Therapy Market Size by Region (2024-2034) & (US$ Million)
Table 136. Asia-Pacific Anti-Infective Therapy Market Share by Region (2018-2024)
Table 137. Asia-Pacific Anti-Infective Therapy Market Share by Region (2024-2034)
Table 138. Latin America Anti-Infective Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 139. Latin America Anti-Infective Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 140. Latin America Anti-Infective Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 141. Middle East & Africa Anti-Infective Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 142. Middle East & Africa Anti-Infective Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 143. Middle East & Africa Anti-Infective Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 144. Anti-Infective Therapy Market Trends
Table 145. Anti-Infective Therapy Market Drivers
Table 146. Anti-Infective Therapy Market Challenges
Table 147. Anti-Infective Therapy Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Infective Therapy Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Anti-Infective Therapy Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Anti-Infective Therapy Market Share by Regions: 2022 VS 2034
Figure 4. Global Anti-Infective Therapy Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Anti-Infective Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Anti-Infective Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Anti-Infective Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Anti-Infective Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Anti-Infective Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Penicillin
Figure 11. Global Penicillin Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Sulphonamides
Figure 13. Global Sulphonamides Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Aminoglycosides
Figure 15. Global Aminoglycosides Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of Fluoroquinolones
Figure 17. Global Fluoroquinolones Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Product Picture of Antifungals
Figure 19. Global Antifungals Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 20. Product Picture of Antiprotozoal
Figure 21. Global Antiprotozoal Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 22. Product Picture of Others
Figure 23. Global Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 24. Global Anti-Infective Therapy Market Size Share by Type: 2022 & 2034
Figure 25. North America Anti-Infective Therapy Revenue Market Share by Type (2018-2034)
Figure 26. Europe Anti-Infective Therapy Revenue Market Share by Type (2018-2034)
Figure 27. Asia-Pacific Anti-Infective Therapy Revenue Market Share by Type (2018-2034)
Figure 28. Latin America Anti-Infective Therapy Revenue Market Share by Type (2018-2034)
Figure 29. Middle East and Africa Anti-Infective Therapy Revenue Market Share by Type (2018-2034)
Figure 30. Home User Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 31. Hospitals/Clinics Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 32. Ambulatory Surgery Centres Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 33. Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 34. Global Anti-Infective Therapy Market Size Share by Application: 2022 & 2034
Figure 35. North America Anti-Infective Therapy Revenue Market Share by Application (2018-2034)
Figure 36. Europe Anti-Infective Therapy Revenue Market Share by Application (2018-2034)
Figure 37. Asia-Pacific Anti-Infective Therapy Revenue Market Share by Application (2018-2034)
Figure 38. Latin America Anti-Infective Therapy Revenue Market Share by Application (2018-2034)
Figure 39. Middle East and Africa Anti-Infective Therapy Revenue Market Share by Application (2018-2034)
Figure 40. Anti-Infective Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 41. Global Top 5 and Top 10 Players Anti-Infective Therapy Market Share in 2022
Figure 42. North America Anti-Infective Therapy Market Share by Country (2018-2034)
Figure 43. United States Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 44. Canada Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 45. Germany Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 46. France Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 47. U.K. Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 48. Italy Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 49. Russia Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 50. Nordic Countries Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 51. Asia-Pacific Anti-Infective Therapy Market Share by Region (2018-2034)
Figure 52. China Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 53. Japan Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 54. South Korea Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 55. Southeast Asia Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 56. India Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 57. Australia Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 58. Latin America Anti-Infective Therapy Market Share by Country (2018-2034)
Figure 59. Mexico Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 60. Brazil Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 61. Middle East & Africa Anti-Infective Therapy Market Share by Country (2018-2034)
Figure 62. Turkey Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 63. Saudi Arabia Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 64. UAE Anti-Infective Therapy Market Size (2018-2034) & (US$ Million)
Figure 65. Bottom-up and Top-down Approaches for This Report